Logo

American Heart Association

  41
  0


Final ID:

RNA editing: a tractable future therapeutic?

  • Weldy, Chad  ( Stanford University , Menlo Park , California , United States )
  • Gan, Li-ming  ( Inst of Medicine , Gothenburg , Sweden )
  • Stafforst, Thorsten  ( University Tübingen , Tuebingen , Germany )
  • Author Disclosures:
    Chad Weldy: DO have relevant financial relationships ; Consultant:AIRNA Biosciences:Active (exists now) ; Consultant:Avidity Biosciences:Active (exists now) | Li-ming Gan: No Answer | Thorsten Stafforst: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Ethical considerations of gene editing technologies

Magnus David, Tabort Holly, Saha Krishanu

Developing single course in vivo gene editing therapies for hyperlipidemia

Kathiresan Sekar, Musunuru Kiran, Ishikawa Kiyotake

More abstracts from these authors:
Discrete Population of Rare SMC Progenitors Gives Rise Exclusively to the Fibrous Cap

Gu Wenduo, Monteiro Joao, Kumar Maya, Quertermous Thomas, Cheng Paul, Jackson William, Zhu Ashley, Li Daniel, Zhao Quanyi, Nguyen Trieu, Worssam Matthew, Ramste Markus, Weldy Chad

Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk

Li Daniel, Palmisano Brian, Weldy Chad, Kundu Ramendra, Kundaje Anshul, Wirka Robert, Quertermous Thomas, Kundu Soumya, Cheng Paul, Gu Wenduo, Jackson William, Zhao Quanyi, Nguyen Trieu, Worssam Matthew, Monteiro Joao

You have to be authorized to contact abstract author. Please, Login
Not Available